- Home
- ACIU vs AFRI Comparison
ACIU vs AFRI Comparison
Compare ACIU & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | AFRI |
|---|---|---|
| Founded | 2003 | 1943 |
| Country | Switzerland | Gibraltar |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.6M | 304.4M |
| IPO Year | 2015 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ACIU | AFRI |
|---|---|---|
| Price | $2.51 | $11.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 138.7K | 21.7K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $706.75 | N/A |
| Revenue Next Year | $321.13 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $8.13 |
| 52 Week High | $4.00 | $11.91 |
Technical Indicators
Market Signals| Indicator | ACIU | AFRI |
|---|---|---|
| Relative Strength Index (RSI) | 41.53 | 55.99 |
| Support Level | $2.13 | $9.58 |
| Resistance Level | $2.68 | $11.26 |
| Average True Range (ATR) | 0.13 | 0.38 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 10.55 | 34.81 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in the production and sale of wheat flour, semolina, pasta, and couscous products. The company operates through the Soft Wheat, Durum Wheat, and Couscous & Pasta segments. Its main brands include MAYMOUNA and TRIA. It generates the majority of its revenue from the Soft Wheat segment.